Kymera’s stock rises after derma investigation expands; Ligand buys Apeiron

Plus, news about AEON Bio­phar­ma, Mod­er­na and Mit­subishi Tan­abe:

Sanofi ex­pands der­ma­tol­ogy tri­als: Kymera Ther­a­peu­tics said that ex­pand­ing the Phase …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.